Biological scientists from the National University of Singapore (NUS) have uncovered how the dengue virus uses its envelope ...

Biological scientists have uncovered how the dengue virus uses its envelope protein to capture human plasmin from a blood meal to enhance the permeability of the mosquito midgut for infection.

The NIH announced that it is launching a phase 2 human challenge trial of AV-1, an investigational monoclonal antibody to ...

Because the weakened virus does not replicate well ... doi:10.1172/JCI21512 Stephenson, J. R. Understanding dengue pathogenesis: Implications for vaccine design. Bulletin of the World Health ...

This review discusses the epidemiology, burden and pathogenesis of dengue, as well as the vaccine candidates currently in clinical development. There is, therefore, an urgent unmet need for a safe ...

Dengue viral infections can result in a range of symptoms. Some people show no symptoms or just have mild signs of the disease, but others develop severe complications. How does the body respond ...

Here, we review the most recent findings on the Crimean–Congo hemorrhagic fever virus molecular biology and pathogenesis, including aspects of virus–host cell interactions. To date ...

Mongkolsapaya et al. performed a detailed analysis of dengue virus-specific T-cell responses in Thai children with dengue. They observed that during acute infection, up to 7% ...

Researchers have uncovered how the dengue virus uses its envelope protein to hijack human plasmin to enhance transmission.